You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 12, Issue 1

January 2020 - 254 articles

Cover Story: The introduction of immunotherapy marks a step forward in the quest for a cure for multiple myeloma. Monoclonal antibodies that target CD38 (daratumumab) and CS1 (elotuzumab) are highly effective and safe options for young and elderly patients. Daratumumab has been included in many regimens and moved from the relapsed to the frontline setting. Furthermore, antibody-drug conjugates such as belantamab mafodotin (GSK2857916) are also under clinical evaluation. Active immunotherapy, aimed at awakening patients’ immune systems against myeloma cells, is of great interest, with bispecific T cell engagers such as AMG420 proving to be effective in heavily pretreated patients in clinical trials. A number of challenges still remain, including the following: finding the correct timing for these agents during the disease course, understanding the mechanisms of resistance, and identifying the antigens to target myeloma cells. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (254)

  • Article
  • Open Access
23 Citations
5,284 Views
9 Pages

Evaluation of Vascular Patterns Using Contact Endoscopy and Narrow-Band Imaging (CE-NBI) for the Diagnosis of Vocal Fold Malignancy

  • Nikolaos Davaris,
  • Anke Lux,
  • Nazila Esmaeili,
  • Alfredo Illanes,
  • Axel Boese,
  • Michael Friebe and
  • Christoph Arens

20 January 2020

The endoscopic detection of perpendicular vascular changes (PVC) of the vocal folds has been associated with vocal fold cancer, dysplastic lesions, and papillomatosis, according to a classification proposed by the European Laryngological Society (ELS...

  • Article
  • Open Access
8 Citations
4,584 Views
14 Pages

Germline Variants in Driver Genes of Breast Cancer and Their Association with Familial and Early-Onset Breast Cancer Risk in a Chilean Population

  • Alejandro Fernandez-Moya,
  • Sebastian Morales,
  • Trinidad Arancibia,
  • Patricio Gonzalez-Hormazabal,
  • Julio C. Tapia,
  • Raul Godoy-Herrera,
  • Jose Miguel Reyes,
  • Fernando Gomez,
  • Enrique Waugh and
  • Lilian Jara

20 January 2020

The genetic variations responsible for tumorigenesis are called driver mutations. In breast cancer (BC), two studies have demonstrated that germline mutations in driver genes linked to sporadic tumors may also influence BC risk. The present study eva...

  • Article
  • Open Access
40 Citations
7,127 Views
19 Pages

Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells

  • Omar Elaskalani,
  • Alice Domenichini,
  • Norbaini Binti Abdol Razak,
  • Danielle E. Dye,
  • Marco Falasca and
  • Pat Metharom

20 January 2020

Background: Extensive research has reported that extracellular ADP in the tumour microenvironment can stimulate platelets through interaction with the platelet receptor P2Y12. In turn, activated platelets release biological factors supporting cancer...

  • Review
  • Open Access
46 Citations
6,739 Views
12 Pages

Role of Interleukin-34 in Cancer

  • Eleonora Franzè,
  • Carmine Stolfi,
  • Edoardo Troncone,
  • Patrizio Scarozza and
  • Giovanni Monteleone

20 January 2020

Cross-talk between cancer cells and the immune cells occurring in the tumor microenvironment is crucial in promoting signals that foster tumor growth and metastasis. Both cancer cells and immune cells secrete various interleukins (IL), which, either...

  • Article
  • Open Access
46 Citations
7,348 Views
17 Pages

Survival-Associated Metabolic Genes in Human Papillomavirus-Positive Head and Neck Cancers

  • Martin A. Prusinkiewicz,
  • Steven F. Gameiro,
  • Farhad Ghasemi,
  • Mackenzie J. Dodge,
  • Peter Y. F. Zeng,
  • Hanna Maekebay,
  • John W. Barrett,
  • Anthony C. Nichols and
  • Joe S. Mymryk

20 January 2020

Human papillomavirus (HPV) causes an increasing number of head and neck squamous cell carcinomas (HNSCCs). Altered metabolism contributes to patient prognosis, but the impact of HPV status on HNSCC metabolism remains relatively uncharacterized. We hy...

  • Review
  • Open Access
29 Citations
8,057 Views
16 Pages

20 January 2020

The MYB binding protein 1A (MYBBP1A, also known as p160) acts as a co-repressor of multiple transcription factors involved in many physiological processes. Therefore, MYBBP1A acts as a tumor suppressor in multiple aspects related to cell physiology,...

  • Article
  • Open Access
24 Citations
6,245 Views
17 Pages

Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate Cancer

  • Filippos Koinis,
  • Paul Corn,
  • Nila Parikh,
  • Jian Song,
  • Ioulia Vardaki,
  • Ioanna Mourkioti,
  • Sue-Hwa Lin,
  • Christopher Logothetis,
  • Theocharis Panaretakis and
  • Gary Gallick

19 January 2020

The overall goal of this study was to elucidate the role of FGFR1 induction in acquired resistance to MET and VEGFR2 inhibition by cabozantinib in prostate cancer (PCa) and leverage this understanding to improve therapy outcomes. The response to cabo...

of 26

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694Creative Common CC BY license